Maven Income and Growth VCT 4 (LON:MAV4 - Get Free Report) issued its quarterly earnings results on Friday. The company reported GBX 0.23 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Maven Income and Growth VCT 4 had a return on equity of 1.48% and a net margin of 31.71%.
Maven Income and Growth VCT 4 Stock Performance
Shares of LON:MAV4 traded down GBX 1 during trading on Wednesday, reaching GBX 50.50. The stock had a trading volume of 16,081 shares, compared to its average volume of 71,822. The business has a fifty day moving average price of GBX 52.36 and a 200-day moving average price of GBX 54.41. The stock has a market cap of £77.70 million, a PE ratio of 3,196.20 and a beta of 0.15. Maven Income and Growth VCT 4 has a 1-year low of GBX 50.50 and a 1-year high of GBX 60.
Maven Income and Growth VCT 4 Company Profile
(
Get Free Report)
Maven Income and Growth VCT 4 PLC is a venture capital trust fund specializes in mature and later stage. It seeks to invest in mature small and medium sized companies operating in a range of sectors and AIM/ISDX quoted companies. The fund invests in the United Kingdom. It does not invest more than £1 million ($1.2 million) in its companies within one year.
Read More
Before you consider Maven Income and Growth VCT 4, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maven Income and Growth VCT 4 wasn't on the list.
While Maven Income and Growth VCT 4 currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.